NPI: 1245493097 · TRACY, CA 95376 · Community Health Clinic/Center · NPI assigned 07/02/2008
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 07/02/2008 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,917 | $667K |
| 2019 | 7,956 | $298K |
| 2020 | 10,212 | $569K |
| 2021 | 15,776 | $843K |
| 2022 | 10,423 | $550K |
| 2023 | 9,947 | $499K |
| 2024 | 9,604 | $512K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,405 | 6,048 | $594K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 1,078 | 1,062 | $542K |
| J3490 | Unclassified drugs | 10,306 | 8,447 | $431K |
| S4993 | Contraceptive pills for birth control | 2,473 | 2,446 | $310K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,984 | 1,952 | $268K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,032 | 2,020 | $261K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 245 | 245 | $241K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,088 | 3,025 | $203K |
| 87806 | 6,344 | 5,455 | $153K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4,094 | 3,895 | $122K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 499 | 497 | $116K |
| 99201 | 1,414 | 1,409 | $96K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,320 | 1,231 | $79K |
| S0190 | Mifepristone, oral, 200 mg | 1,075 | 1,056 | $64K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 3,568 | 2,316 | $56K |
| A4267 | Contraceptive supply, condom, male, each | 5,010 | 4,918 | $53K |
| 11981 | 213 | 213 | $52K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 199 | 199 | $51K |
| 58300 | 481 | 248 | $48K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,317 | 1,311 | $39K |
| 99401 | 1,514 | 1,485 | $29K | |
| 99000 | 4,857 | 4,722 | $19K | |
| 81025 | 5,027 | 4,910 | $15K | |
| 11976 | 222 | 115 | $13K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 15 | 15 | $12K |
| 83986 | 4,197 | 3,665 | $12K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 3,257 | 3,180 | $11K |
| 99402 | 354 | 354 | $11K | |
| 58301 | 266 | 141 | $8K | |
| S5000 | Prescription drug, generic | 1,047 | 1,008 | $8K |
| S0191 | Misoprostol, oral, 200 mcg | 1,120 | 1,089 | $4K |
| 85018 | 711 | 675 | $3K | |
| 99001 | 481 | 474 | $3K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 421 | 400 | $2K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 154 | 154 | $2K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 149 | 145 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 48 | 47 | $2K |
| 81002 | 694 | 678 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14 | 14 | $367.81 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 56 | 53 | $280.06 |
| 0270 | 43 | 28 | $253.95 | |
| 98966 | 14 | 14 | $128.80 | |
| 86901 | 29 | 29 | $66.42 |